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Abstract
Three-dimensional collagen–chitosan scaffolds were fabricated with type I collagen and
chitosan through freeze drying and glutaraldehyde cross-linking. Dermal fibroblasts were
isolated from neonatal Sprague-Dawley rat skin by dispase II/collagenase I digestion. The
fibroblasts were then seeded into the scaffolds to construct tissue-engineered dermis. The
microstructure of the scaffolds as well as the fibroblasts’ proliferation, cytokine secretion and
cell cycle were investigated. Flow cytometry analysis indicated that cells in the scaffolds
proliferated steadily. IL-6 concentration measurement by the ELISA test suggested that the
scaffolds could promote secretion of the fibroblasts’ cytokine. These results show that the
fibroblasts and the scaffolds interact well with each other, and the fibroblasts have better
proliferation ability and biological activity in the scaffolds than in monolayer culture. The
scaffolds are a promising candidate for tissue repair and regeneration with enhanced
biostability and good cytocompatibility.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
From materials science viewpoint, a tissue or organ can be
considered as a complex material composed of cells and
extracellular matrix (ECM) released by the cells [1]. The three-
dimensional structure of the artificial ECM–tissue engineering
scaffolds provides space for cell adhesion, growth and ECM
regeneration [2]. Collagen–chitosan scaffolds have good
biocompatibility, controllable biodegradability and a suitable
mechanical property. They have been approved to be ideal
scaffolds for skin tissue engineering [3–7]. Collagen is by
far the most abundant component of the ECM. It contains
specific cell adhesion sites such as arginine–glycine–aspartate
(RGD) groups. The RGD group actively induces cellular
adhesion by binding to integrin receptors; this interaction plays
an important role in cell growth and cell differentiation [4].
However, the fast biodegrading rate and the low mechanical
strength of the untreated collagen scaffold limit the further use
of collagen. Cross-linking of the collagen-based scaffolds
is an effective method to modify the biodegrading rate
and to optimize the mechanical property. Glutaraldehyde
(GA) is a kind of bifunctional cross-linking reagent that
can bridge amino groups between two adjacent polypeptide
chains. Chitosan (poly-(1→4)-β-D-glucosamine) is derived
from chitin by deacetylation. It has many advantages
for wound healing such as hemostasis, accelerating tissue
regeneration and the fibroblast synthesis of collagen. In
addition, chitosan can function as a bridge to increase the cross-
linking efficiency of GA in the collagen-based scaffolds since
it has a large number of amino groups in its molecular chain
[5]. Nevertheless, the poor mechanical strength of chitosan
limits its applications in tissue engineering [8]. Therefore,
chitosan is combined with collagen to avoid its disadvantages.
Three-dimensional (3D) cell culture on the collagen–
chitosan scaffolds is quite different from standard two-
dimensional (2D) culture systems [9–11], so it is important to
study the biological activity of cells growing on the scaffolds.
Cells in a living organism are surrounded by other cells
and ECM. To mimic this environment, the culture of cells
in a 3D space is more physiologically relevant, compared
to 2D monolayer cultures. The fate of the cells on the
implant is decided by the dynamic balance of cell proliferation,
differentiation and apoptosis, which can be measured by flow
cytometry [12].
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Fibroblasts are the main component of dermal cells. They
are known to secrete a wide variety of cytokines including
inflammatory mediators, growth factors, matrix polymers and
catabolic enzymes [13]. Interleukin-6 (IL-6) is a pleiotropic
cytokine that is involved in the growth and differentiation
of numerous cell types. Increased levels of IL-6 have been
associated with a number of skin diseases and skin barrier
repair [14]. In addition, it may play pivotal roles in inducing or
restricting the accumulation of connective tissue by altering the
immigration and proliferation of fibroblasts in inflammatory
lesions [15].
Previous studies of collagen–chitosan scaffolds mainly
focused on the preparation and characterization of the
scaffolds. Biological evaluation only involved a simple
cytotoxic test or an animal experiment [16–18]. An in-
depth study of the cytokine assay and cell cycle analysis was
still not performed on such scaffolds. We have synthesized
collagen–chitosan scaffolds as previously described [16]. The
dermal fibroblasts obtained from Sprague-Dawley (SD) rats
are seeded into the scaffolds for 3D culture. This study
presents the data on the microstructure, cytotoxicity and the
release of IL-6 from fibroblasts after exposure to the collagen–
chitosan scaffolds. The cell cycle of fibroblasts on the scaffolds
is also investigated.
2. Materials and methods
2.1. Materials
Healthy neonatal SD rats less than 24 h of age were provided
by the Cancer Research Center of Medical College of Xiamen
University. Dulbecco’s modified Eagle medium (high glucose)
and a 100× penicillin–streptomycin solution were purchased
from Hyclone (USA). MTT was from Amresco (USA).
Dispase II and collagenase I were obtained from Roche
Applied Science (Germany). RnaseA and propidiumiodide
were from Sigma (USA). The culture plates were purchased
from Corning (USA). Trypsin was a commercial product from
Shanghai Sangon (China). The newborn calf serum was
from Beijing BioEev-Tech (China). Chitosan (Mw: 2 ×
105, 90.6% deacetylated) was purchased from the Third
Institute of Oceanography of the State Oceanic Administration
of China. Collagen type I was provided by the Institute
of Biomedical Engineering, Chinese Academy of Medical
Science and Peking Union Medical College. The IL-6 ELISA
kit was obtained from Jingmei Biotech (China).
2.2. Fibroblast isolation and culture
Healthy neonatal SD rats were killed by carbon dioxide
suffocation and immersed in 75% ethanol; then their dorsal
skin was removed by ophthalmic scissors. The underlying
subcutaneous tissue was carefully scraped off with a scalpel.
The skin was washed twice in phosphate buffer saline (PBS)
supplemented with penicillin (100 U ml−1) and streptomycin
(100 U ml−1), and then diced into 0.5 cm × 1 cm sized
tissues. These pieces were digested with different enzymes
respectively: (1) 0.25% trypsin and 0.02% ethylenediamine
tetraacetic acid (EDTA) for 1 h at 37 ◦C, (2) 0.25% type I
collagenase for 1 h at 37 ◦C and (3) 2.4 U ml−1 dispase II
at 4 ◦C overnight. The epidermis was then separated from
the dermis with sterile tweezers. The dermis was collected
and washed with PBS containing penicillin and streptomycin,
and then cut into smaller pieces and moved into a 15 ml
conical tube containing 0.25% collagenase. After digestion
at 37 ◦C for 30 min, the tissue cells were dispersed into
suspension by pipetting repeatedly. The digestion was
discontinued by adding DMEM; then the digesting solution
was filtered through a copper mesh (cell strainer, 200 meshes)
and centrifuged at 1000 rpm for 5 min, and washed three
times. The cell suspension was cultured at 37 ◦C, 5% CO2,
and 95% humidity in the DMEM complete medium. The
culture medium was changed every 3 days. The fourth-passage
fibroblasts were used for seeding on the scaffold.
2.3. Preparation of the reconstructed dermis
Collagen–chitosan scaffolds were prepared by the previous
method [16]. Briefly, 0.8% (mass) collagen solution and 0.8%
(mass) chitosan solution were prepared in 0.5 mol l−1 acetic
acid. Then the collagen solution and chitosan solution were
homogenized by stirring overnight with a volume ratio of 9:1.
The final solution was poured into six-well culture plates and
frozen at −80 ◦C for 12 h, then lyophilized in a vacuum
lyophilizer (Labconco, USA) for 24 h, cross-linked by 0.25%
(mass) GA at 4 ◦C for 12 h and rinsed in triply distilled
water (30 min × 2 times) and ultra-pure water (15 min ×
6 times). Then it was stored overnight at −20 ◦C, and freeze-
dried again. The scaffolds were immersed in 70% ethanol for
30 min for disinfection, followed with solvent exchange by
PBS (30 min × 4 times). 100 μl of complete medium was first
added to each well of a new six-well plate; the scaffolds were
then attached on the plate and seeded with 500 μl of dermal
fibroblast suspension at a density of 1 × 106 cells ml−1. After
incubation for 4 h, 2 ml of complete medium was added and
cultured in a 5% CO2 incubator at 37 ◦C; the culture medium
was changed every 2–3 days. The PBS and culture medium
were supplemented with penicillin and streptomycin.
2.4. Microstructure observation
The collagen–chitosan scaffolds were gold-sputtered in
vacuum and examined by a scanning electron microscope
(SEM, LEO1530) at 20 keV. To get the porosity, a dried
scaffold was cut into 1 cm × 1 cm square pieces, the thickness
was measured and the volume was calculated as V1. After
weighing (W 1), the sample was immersed in absolute alcohol.
The weight of the saturated sample was W 2. The porosity was
calculated from the following equation, where ρ is the density
of ethanol: porosity = (W 2 − W 1)/ρ/V1 [19].
2.5. MTT assay
The MTT assay was performed to analyze the proliferation
condition of fibroblasts in the collagen–chitosan scaffolds.
Circular scaffolds were prepared using a hole punch. After
soaking in 70% ethanol for 30 min and washed five times in
the PBS, the scaffolds were placed at the bottom of a 96-well
2
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Figure 1. HE staining of SD rat’s skin treated by different enzymes (HE × 40). (A) Untreated skin; (B) 0.25% trypsin–0.02% EDTA
(37 ◦C, 1 h); (C) 0.25% type I collagenase (37 ◦C, 1 h); (D) 2.4 U ml−1 dispase (4 ◦C, overnight).
plate. Approximately 5 × 104 primary fibroblasts (fourth
passage) were added to each well and cultured in 200 μl
of medium at 37 ◦C. Cells were grown in the scaffolds for
1, 3, 5, 7 and 14 days respectively. Parallel wells with no
scaffolds were seeded with the same number of fibroblasts, for
control purposes. The culture medium was removed from each
well before measurement. 100 μl of serum-free medium was
immediately added into each well. 50 μl of MTT in the PBS at
a concentration of 2.5 mg ml−1 was then added into each well.
The culture plate was wrapped in aluminum foil and incubated
for 4 h at 37 ◦C. Then 150 μl of DMSO was added to each
well; the medium and MTT were removed. The solution was
transferred to a new 96-well plate. OD values at a wavelength
of 490 nm (OD490) were measured with a microplate reader
(Bio-Rad Laboratories, USA).
2.6. Preparation for the cytokine assay
The fourth-passage fibroblasts were seeded (1 × 104
cells/well) on the scaffolds in 96-well culture plates. After
1, 3 and 5 days, the IL-6 levels in cell-free supernatants were
determined using commercially available Rat IL-6 ELISA
kits containing the anti-rat IL-6 monoclonal antibodies. The
supernatant samples and standard recombinant IL-6 were
incubated at 37 ◦C for 90 min. Subsequently, the plates were
washed four times with a wash buffer, 100 μl of biotinylated
antibody working solution was added and the plates were
incubated at 37 ◦C for 1 h. Then the plates were washed four
times again, 100 μl of working enzyme solution was added
and the plates were incubated at 37 ◦C for 30 min. After
washing four times, 100 μl of substrate solution was added
and incubated at 37 ◦C for 10–20 min in the dark; the reaction
was terminated with 100 μl of stop solution. A microplate
reader (Bio-Rad Laboratories, USA) was used to measure
the absorbance at 450 nm (OD450). Sample concentrations
were read from the dose–response curve obtained with the
reference recombinant IL-6. Six measurements were taken
for each time period, and mean values were calculated.
2.7. Cell cycle analysis of fibroblasts
The fibroblasts were seeded on the scaffolds in a six-well plate
at a density of 1 × 106 cells ml−1. The samples were added
with 0.25% collagenase (type I) after cultivation for 3, 7 and
14 days, respectively. In the digestive process, the plates were
shaken continuously at 37 ◦C on a shaker. The cell suspension
was centrifuged at 1000 rpm for 10 min and the supernatant
was discarded; then the cells were washed twice with the PBS
and resuspended in 300 μl of PBS. Ice-cold ethanol (70%)
was slowly added, and the cells were fixed at 4 ◦C for 24 h.
The cell suspension was centrifuged and resuspended in the
PBS, centrifuged and washed twice, treated with 100 mg l−1
RNaseA at room temperature for 30 min. Then 50 mg l−1
PI was added to stain the cells for 30 min in the dark. The
cell cycle is analyzed with flow cytometry (Beckman Coulter
EPICS XL) with 488 nm excitation and a 620 nm band-pass
filter for red fluorescence of PI.
3. Results and discussion
3.1. Dermal fibroblast isolation
Epidermal–dermal separation is commonly achieved by
treatment with proteolytic enzymes such as collagenase,
trypsin or dispase. Figure 1(A) shows the two main layers of
3
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Figure 2. SEM photos of the collagen–chitosan scaffolds. Scale bar: (A) 500 μm, (B) 200 μm. (A) Surface structure; (B) section structure.
normal skin: the upper epidermis and the lower dermis. The
epidermal layer is relatively thin and securely attached to the
underlying dermis. Trypsin treatment caused a supra-basal
separation which left basal cells still attached to the dermis
(figure 1(B)), because trypsin could disrupt the suprabasal
desmosomes between the keratinocytes [20]. Collagenase
digested collagen fiber of the dermis, but the separated
epidermis was attached by many dermal cells (figure 1(C)). It
was, therefore, difficult to obtain intact dermis. Treatment with
dispase II caused a complete dermal–epidermal separation
(figure 1(D)). Dispase is a bacterial neutral protease which
is obtained from the culture filtrate of Bacillus polymyxa.
It selectively cuts the hemidesmosomes at the level of the
basement membrane. Dispase has very low cytotoxicity, and
has proven to be a rapid and effective agent for separating
epidermis and dermis [21]. These advantages led us to
choose dispase II for separating dermis from epidermis. Then
fibroblasts were further isolated from the skin dermis by
collagenase I.
3.2. Microstructure of the scaffolds
The porosity and pore size of biomaterial scaffolds play a
critical role in cell adhesion and proliferation. SEM images
of the porous structure of the scaffolds are shown in figure 2.
The scaffolds are highly porous (porosity 87.4 ± 2.2%) and
the pores are well distributed in multilayers. The pore sizes
are in the range of 62–229 μm, and the average pore size is
159.4 ± 66.6 μm. The porosity is interconnected allowing in-
growth of cells and diffusion of nutrients. These are the desired
properties for scaffolds intended for tissue engineering.
3.3. Proliferation of fibroblasts in the 3D and 2D culture
The MTT assay was performed to compare the viabilities
of fibroblasts growing in the 3D scaffolds and 2D plates’
culture. Cell proliferation was expressed as the OD value
of absorbance. The MTT data are shown in figure 3. The
OD values for both groups increase with culture time in the
first 5 days. OD values at the first 7 days of the 2D culture
group are higher than that of 3D culture group. But on day
14, the OD value of the 3D culture group is much higher than
that of the 2D culture group. These data demonstrate that
fibroblasts proliferate slower in the 3D scaffolds than in the















Figure 3. The proliferation of fibroblasts on the scaffolds detected
with the MTT test.
parallel 2D culture plates in the first week. But cells seeded on
the culture plates are saturated on day 5 and contact inhibition
of the cells takes place, leading to decreased cells on day 7.
A significant loss of cellular viability is seen on day 14 for
the 2D culture (p < 0.05, Student’s t-test for paired data). In
contrast, cells seeded in the scaffolds proliferate steadily for
14 days. This indicated that the scaffolds had good biological
activity. The effects of the scaffolds on the cell behavior could
be explained by the specific binding of amino acids of collagen
for cell integrin receptors. In addition, chitosan may provide
more amino groups for cell adhesion and proliferation due to
the affinity between positively charged ammonium groups of
chitosan and negatively charged cell membrane surfaces [4].
3.4. Release of proinflammatory cytokine
The effect of the scaffolds on the release of proinflammatory
cytokine IL-6 was evaluated. The results are shown in figure 4.
The amount of IL-6 released in the 3D scaffolds was compared
with that released in the 2D culture. The concentration of IL-
6 for both groups increases with the culture time for 5 days.
This is consistent with the cell proliferation test, indicating that
cellular viability affected the cytokine secretion level. On days
1, 3 and 5, the overall viabilities of 3D-cultured cells are lower
than those of the 2D-cultured cells (figure 3), but the level of
IL-6 does not show a similar trend in figure 4, indicating that
the cytokine secretion should also be affected by other factors.
On day 1, more IL-6 is released from 3D-cultured cells than
4
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Figure 4. The measurement of IL-6 concentrations produced by the
fibroblasts on the scaffolds.
Table 1. The cell cycle of fibroblasts on the scaffolds.
Cell cycle (%)
Time G0/G1 S G2/M Cell death (%)
3 days 55.4 6.96 36.2 1.61
7 days 51.5 7.62 39.1 2.01
14 days 50.4 5.86 40.8 3.14
from 2D-cultured cells. This may potentially be due to the
stimulation of the 3D scaffolds to the fibroblasts. The IL-6
concentrations for both groups show no significant difference
on day 3 and 5 (p > 0.05, Student’s t-test for paired data).
The present study shows that the scaffolds do not stimulate
the production of IL-6. We can expect that the material as
a wound dressing will not induce the tissue inflammatory or
immune response.
3.5. Cell cycle analysis of fibroblasts
In this study, propidium iodide was used for cell stain, and
then the biological cell cycle was characterized by synthesis
and duplication of DNA before division. In cell morphology,
four stages can be discerned: G1, S, G2 and M. After a cell
cycle, cell will choose to stop (G0) or enter a new cell cycle.
During the G0 and G1 stage, only one set (2n for fibroblast) is
present, during G2 and M stages the duplicate set is present as
well (4n), and during the S stage an intermediate amount can
be found. For apoptotic cells, DNA is degraded to the sub-2n
level. The percentage of cells in different stages is determined
by the DNA content that can be assessed by flow cytometry of
these cells after staining the DNA with PI [12]. After being
cultured in the scaffolds for 3, 7 and 14 days, the percentage
of cells in the G0/G1, S and G2/M phases and percentage of
cell death are given in table 1. These data indicate that most
fibroblasts seeded on the scaffolds come in the normal cell
cycle. The cell death rate is very low, indicating that there is
no toxic molecule triggered by the scaffolds. The percentages
of fibroblasts cultured in the dish for 3 days in the G0/G1, S,
G2/M phases and apoptotic cells are 57.8%, 37.8%, 4.4% and
0.5%, respectively. Compared with fibroblasts cultured in the
scaffolds, the S phase cells increase apparently, and the G2/M
phase cells decrease remarkably. This result demonstrates that
the collagen–chitosan scaffolds promote the S–G2/M phase
transition.
4. Conclusions
In this study, microporous collagen–chitosan scaffolds with
controllable porosity were produced from solutions of collagen
and chitosan by freeze drying and cross-linking with GA.
Dermal fibroblasts were isolated from the SD rat skin by
dispase II/collagenase I digestion. The MTT assay shows
that fibroblasts seeded in the scaffolds proliferate steadily over
14 days. IL-6 analysis indicates that the scaffolds do not
induce the tissue inflammatory or immune response. The
results of flow cytometry show that most fibroblasts seeded
on the scaffolds enter a normal cell cycle. In addition, the
scaffolds would not trigger cell death. All these results suggest
that the collagen–chitosan scaffolds cross-linked by GA are a
promising candidate for tissue repair and regeneration with
enhanced biostability and good cytocompatibility.
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